Clinically, FGFR amplification occurs in approximately 20% of breast cancers47, 48 and FGFR1 protein overexpression has particularly been linked to poor clinical outcomes in patients with the Luminal A breast cancer subtype49. The gene discussed is FGFR1; the disease is breast cancer.